Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bipolar disorder
bipolar disorder
Luye submits NDA for schizophrenia, bipolar disorder therapy
BioCentury
Sat, 03/30/19 - 01:02 pm
Luye Pharma Group
Rykindo
schizophrenia
bipolar disorder
FDA
Antipsychotic from Lundbeck, Otsuka flops again in PhIII trials — this time in bipolar patients
Endpoints
Thu, 02/14/19 - 05:45 pm
Lundbeck
Otsuka
brexpiprazole
anti-psychotic
schizophrenia
bipolar disorder
FDA Grants Breakthrough Therapy Designation to First Oral Drug for Suicidal Bipolar Depression
CP Wire
Tue, 11/13/18 - 09:44 am
NRX-101
NeuroRx
FDA
bipolar disorder
breakthrough therapies
Otsuka's dose-tracking digital pill charts its first course to market with Magellan
Fierce Pharma
Wed, 09/5/18 - 07:02 pm
Otsuka
Abilify MyCite
smart pills
digital pills
bipolar disorder
schizophrenia
Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression Mostly Positive
CP Wire
Tue, 04/3/18 - 09:47 am
cariprazine
bipolar disorder
Allergan
Gedeon Richter
clinical trials
Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression Mostly Positive
Tue, 04/3/18 - 09:09 am
Allergan
Geodon Richter
Vraylar
bipolar disorder
23andMe, Lundbeck unveil mega investigation of genetics' role in depression
BioPharma Dive
Thu, 08/3/17 - 10:58 am
23andMe
Lundbeck
genetics
bipolar disorder
major depressive disorder
Allergan and Richter win FDA approval for a once-rejected schizophrenia pill
Fierce Biotech
Thu, 09/17/15 - 05:21 pm
Allergan
Geodon Richter
FDA
cariprazine
antipsychotic
bipolar disorder
schizophrenia
Hope And Hype For New Type Of Antidepressant
Forbes
Wed, 06/24/15 - 10:09 am
antidepressants
D-cycloserine
NeuroRx
bipolar disorder
Will Schizophrenia and Bipolar Patients Trust Generic Abilify?
24/7 Wall St
Wed, 04/29/15 - 08:18 am
schizophrenia
bipolar disorder
generics
Abilify
Bristol-Myers Squibb
Teva Final Phase III Study of Armodafinil Did Not Meet Primary Endpoints
Street Insider
Sat, 08/31/13 - 12:02 pm
Teva
NUVIGIL
bipolar disorder
Teva reports top-line results from Phase III study of NUVIGIL
The Fly on the Wall
Fri, 08/30/13 - 12:27 pm
Teva
NUVIGIL
bipolar disorder
Teva to market Alexza agitation treatment in the U.S.
Reuters
Wed, 05/8/13 - 10:44 am
Teva
Alexza
Adasuve
agitation
schizophrenia
bipolar disorder
Alexza's agitation drug gets FDA approval
Reuters
Sat, 12/22/12 - 12:29 pm
Alexza
Adasuve
schizophrenia
bipolar disorder
Elan Takes Another Swing
Motley Fool
Fri, 09/7/12 - 12:04 pm
Elan
ELND005
bipolar disorder
Mylan selling generic version of the allergy drug Clarinex and bipolar disorder drug Lithobid
Yahoo/AP
Tue, 07/3/12 - 12:21 pm
generics
Clarinex
bipolar disorder
Mylan
Lithobid
Alexza rockets 30% on FDA update
Marketwatch
Fri, 06/22/12 - 04:00 pm
Alexza
FDA
bipolar disorder
Adasuve
Teva launches generic Symbyax in the United States
The Fly on the Wall
Thu, 06/21/12 - 05:51 pm
generics
Teva Pharmaceuticals
Symbyax
Eli Lilly
bipolar disorder
Pivotal FDA Decision Upcoming For Alexza
Seeking Alpha
Thu, 04/12/12 - 11:37 am
FDA
Alexza
Adasuve
schizophrenia
bipolar disorder
FDA approves first generic versions of Zyprexa
Yahoo/AP
Mon, 10/24/11 - 04:09 pm
FDA
Eli Lilly
Zyprexa
generics
bipolar disorder
schizophrenia
Teva Pharmaceuticals
Dr Reddy's
antipsychotics
Pages
« first
‹ previous
1
2
3
4
next ›
last »